FX1

• Catalog number
  B2010-25
• Price
  Please ask
• Size
  25 mg

• Alternative_name
  (5Z)-5-(5-Chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid
• Description
  FX1 is a potent B cell lymphoma 6 (BCL6) inhibitor. FX1 displays 10-fold greater potency than endogenous corepressors and binds an essential region of the BCL6 lateral groove. FX1 disrupts formation of the BCL6 repression complex, reactivated BCL6 target genes, and mimics the phenotype of mice engineered to express BCL6 with corepressor binding site mutations. 
• CAS Number
  1426138-42-2 
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₁₄H₉ClN₂O₄S₂
• Molecular Weight
  368.81
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO
• Handling
  Protect from air and light
• Tag Line
  A potent B cell lymphoma 6 (BCL6) inhibitor
• Storage Condition
  -20°C
• Shipping Condition
  gel pack
• Shelf Life
  36 months
• PubChem CID
  66488970
• PubChem CID Link
• SMILES
  C1=CC2=C(C=C1Cl)C(=C3C(=O)N(C(=S)S3)CCC(=O)O)C(=O)N2
• InChi
  InChI=1S/C14H9ClN2O4S2/c15-6-1-2-8-7(5-6)10(12(20)16-8)11-13(21)17(14(22)23-11)4-3-9(18)19/h1-2,5H,3-4H2,(H,16,20)(H,18,19)/b11-10-
• InChi Key
  VISHSGZPGQKEFX-KHPPLWFESA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  FX1  
• Short name
  FX1
• Alternative name
  FX1

Product images

Similar products